Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ODM-207 is an inhibitor of bromodomain and extra terminal domain (BET) bromodomains. It reduces the proliferation of isolated human metastatic apocrine sweat gland cancer cells (IC50 = 1.99 µM).1 ODM-207, in combination with the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib (Item No. 10621), decreases proliferation of, and induces DNA double-strand breaks in, isolated human metastatic apocrine sweat gland cancer cells deficient in partner and localizer of BRCA2 (PALB2; IC50 = 650 nM).
WARNING This product is not for human or veterinary use.
1. Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma. Oncotarget 12(11), 1100-1109 (2021).